Full text is available at the source.
Novel Prognostic Implications of Methylated RNA and Demethylases in Resected HCC and Background Liver Tissue
Methylated RNA and RNA-Modifying Enzymes as New Predictors in Removed Liver Cancer and Nearby Liver Tissue
AI simplified
Abstract
The expression of mA demethylases FTO and ALKBH5 is significantly lower in hepatocellular carcinoma (HCC) than in non-cancerous tissues (both p<0.001).
- Global mA quantification showed no significant difference between HCC and non-cancerous liver tissue.
- Lower expression levels of the mA demethylases FTO and ALKBH5 in HCC could suggest their role in cancer development.
- In non-cancerous tissues, low ALKBH5 expression is associated with worse recurrence-free survival (median of 16.3 vs. 38.9 months, p=0.001).
- These findings may indicate that mA and its demethylases in surrounding non-cancerous tissues are involved in HCC malignancy after surgical resection.
AI simplified